{"id":"NCT04728802","sponsor":"Applied Biology, Inc.","briefTitle":"Proxalutamide Treatment for Hospitalized COVID-19 Patients","officialTitle":"Proxalutamide Treatment for Hospitalized COVID-19 Patients","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2021-02-01","primaryCompletion":"2021-04-15","completion":"2021-04-15","firstPosted":"2021-01-28","resultsPosted":"2021-06-23","lastUpdate":"2021-06-24"},"enrollment":645,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Covid19","SARS (Severe Acute Respiratory Syndrome)"],"interventions":[{"type":"DRUG","name":"Proxalutamide","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Proxalutamide + Usual Care","type":"ACTIVE_COMPARATOR"},{"label":"Placebo + Usual Care","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to assess the efficacy and safety of Proxalutamide as a treatment for hospitalized COVID-19 male and female patients.","primaryOutcome":{"measure":"14 Day Recovery Rate","timeFrame":"Day 14","effectByArm":[{"arm":"Proxalutamide + Usual Care","deltaMin":258,"sd":null},{"arm":"Placebo + Usual Care","deltaMin":117,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":8,"countries":["Brazil"]},"refs":{"pmids":["32237190","32301221","32446821","32387456","33135263","32977355"],"seeAlso":["http://appliedbiology.com/AppliedBiologyTheAndroCoVProject.html"]},"adverseEventsSummary":{"seriousAny":{"events":38,"n":317},"commonTop":["Diarrhea"]}}